RMgmDB - Rodent Malaria genetically modified Parasites

Summary

RMgm-5552
Malaria parasiteP. berghei
Genotype
DisruptedGene model (rodent): PBANKA_0810400; Gene model (P.falciparum): PF3D7_0909200; Gene product: GDP-fucose protein O-fucosyltransferase 2 (O‑Fucosyltransferase; POFut2)
Transgene
Transgene not Plasmodium: GFP
Promoter: Gene model: Not available; Gene model (P.falciparum): Not available; Gene product: Not available
3'UTR: Gene model: Not available; Gene product: Not available
Insertion locus: Gene model: PBANKA_1110700; Gene product: Stearoyl-CoA desaturase (Scd)
Phenotype Sporozoite; Liver stage;
Last modified: 26 September 2024, 12:53
  *RMgm-5552
Successful modificationThe parasite was generated by the genetic modification
The mutant contains the following genetic modification(s) Gene disruption, Introduction of a transgene
Reference (PubMed-PMID number) Reference 1 (PMID number) : 38421807
MR4 number
Parent parasite used to introduce the genetic modification
Rodent Malaria ParasiteP. berghei
Parent strain/lineP. berghei ANKA
Name parent line/clone Not applicable
Other information parent line
The mutant parasite was generated by
Name PI/ResearcherSrivastava PN, Mishra A
Name Group/DepartmentDivision of Molecular Microbiology and Immunology
Name InstituteCSIR-Central Drug Research Institute
CityLucknow
CountryIndia
Name of the mutant parasite
RMgm numberRMgm-5552
Principal namePOFut2 KO
Alternative name
Standardized name
Is the mutant parasite cloned after genetic modificationYes
Phenotype
Asexual blood stageNot different from wild type
Gametocyte/GameteNot different from wild type
Fertilization and ookineteNot different from wild type
OocystNot different from wild type
SporozoiteSalivary gland sporozoites were injected into C57BL/6 mice. A delay of 1 day in the prepatent period was observed in KO-infected mice compared to the wild type (WT)-infected mice. To analyze the parasite burden in the liver, infected mouse livers were harvested at 40 hpi, and parasite biomass was quantified by measuring 18S rRNA copy number using real-time PCR. A significant decrease in 18S rRNA copy number in KO parasites was found. In in vitro cultures liver stages (EEFs) were observed with normal morphology at 40 hpi, which, upon quantification, revealed a decrease in EEF numbers, while EEF areas remained similar to those of WT EEFs. All POFut2 KO EEFs matured into hepatic merozoites normally. A two-step IFA-based invasion assay was used to assess sporozoite invasion. The invasion of POFut2 KO sporozoites was approximately half compared to WT parasites. POFut2 KO sporozoites showed reduced gliding motility.
Liver stageSalivary gland sporozoites were injected into C57BL/6 mice. A delay of 1 day in the prepatent period was observed in KO-infected mice compared to the wild type (WT)-infected mice. To analyze the parasite burden in the liver, infected mouse livers were harvested at 40 hpi, and parasite biomass was quantified by measuring 18S rRNA copy number using real-time PCR. A significant decrease in 18S rRNA copy number in KO parasites was found. In in vitro cultures liver stages (EEFs) were observed with normal morphology at 40 hpi, which, upon quantification, revealed a decrease in EEF numbers, while EEF areas remained similar to those of WT EEFs. All POFut2 KO EEFs matured into hepatic merozoites normally. A two-step IFA-based invasion assay was used to assess sporozoite invasion. The invasion of POFut2 KO sporozoites was approximately half compared to WT parasites. POFut2 KO sporozoites showed reduced gliding motility.
Additional remarks phenotype

Mutant/mutation
The mutant lacks expression of POFut2 and expresses GFP (under a constitutive promoter).

Protein (function)
Glycosylation is one of the most important post-translational modifications (PTMs) in many proteins. The attachment of carbohydrate residues serves a range of diverse functions, such as the generation of antigenic variation, subcellular localization, and proper folding of protein domains. A large and diverse group of proteins subjected to glycosylation belongs to the TSR superfamily. TSR domains, which play essential roles in cell adhesion and motility, contain six conserved cysteines forming three disulfide bonds. The Plasmodium proteome has several TSR domain-containing proteins. These proteins include circumsporozoite and TRAP-related protein (CTRP), thrombospondin-related anonymous protein (TRAP), and circumsporozoite protein (CSP) in the ookinete and sporozoite stages.3−5 The TSR domains of these essential
proteins are O-fucosylated by POFut2 on the canonical serine/threonine residue of the CXX(S/T)C motif. Both O-linked and C-linked glycosylation events play an important role in the folding and export of TSR domain-containing proteins.
POFut2 has been characterized with conflicting results. Initially,  Plasmodium  falciparum POFut2 was found to be important for both host and vector infections.  While it was found to be nonessential for blood stage infection, it was indicated that a lack of PfPOFut2 affects ookinete implantation, resulting in fewer oocysts. The obtained sporozoites also had impaired liver infectivity in chimeric mice containing humanized livers. However, some studies also reported a nonessential role of POFut2 in P. berghei (see RMgm-4678). Here, we disrupted the POFut2 gene in Plasmodium berghei and demonstrated that POFut2 KO parasites develop normally in blood and mosquito stages but show reduced infectivity in mice. We found that the reduced infectivity of POFut2 KO sporozoites was due to a diminished level of TRAP that affected the parasite gliding motility and hepatocyte infectivity.

Phenotype
Salivary gland sporozoites were injected into C57BL/6 mice. A delay of 1 day in the prepatent period was observed in KO-infected mice compared to the wild type (WT)-infected mice. To analyze the parasite burden in the liver, infected mouse livers were harvested at 40 hpi, and parasite biomass was quantified by measuring 18S rRNA copy number using real-time PCR. A significant decrease in 18S rRNA copy number in KO parasites was found. In in vitro cultures liver stages (EEFs) were observed with normal morphology at 40 hpi, which, upon quantification, revealed a decrease in EEF numbers, while EEF areas remained similar to those of WT EEFs. All POFut2 KO EEFs matured into hepatic merozoites normally. A two-step IFA-based invasion assay was used to assess sporozoite invasion. The invasion of POFut2 KO sporozoites was approximately half compared to WT parasites. POFut2 KO sporozoites showed reduced gliding motility.

Additional information
To check the fucosylation status of TRAP and CSP in POFUT2 KO lines, Western blotting was performed with sporozoite secreted proteins using ulex europaeus agglutinin I (UEA I). UEA I specific signal was found in WT sporozoites but not in the POFUT2 KO parasites. The UEA I identified signals were specific to TRAP and CSP, which was confirmed by reprobing the blot with anti-TRAP and anti-CSP antibodies.
Since O-fucose is added to the TSR domains of sporozoite surface proteins CSP and TRAP,6  the levels of these two proteins was checked by IFA and immunoblotting. The levels of TRAP but not CSP were reduced in POFut2 KO sporozoites. The decreased levels of TRAP were at the protein level and not at the transcript level. The Plasmodium TRAP-TSR domain was found to be always modified with C-mannosylation but not always with O-fucosylation, possibly due to the loss during the experiment and hence not detected.

Other mutants


  Disrupted: Mutant parasite with a disrupted gene
Details of the target gene
Gene Model of Rodent Parasite PBANKA_0810400
Gene Model P. falciparum ortholog PF3D7_0909200
Gene productGDP-fucose protein O-fucosyltransferase 2
Gene product: Alternative nameO‑Fucosyltransferase; POFut2
Details of the genetic modification
Inducable system usedNo
Additional remarks inducable system
Type of plasmid/construct used(Linear) plasmid double cross-over
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid
Partial or complete disruption of the geneComplete
Additional remarks partial/complete disruption
Selectable marker used to select the mutant parasitehdhfr/yfcu
Promoter of the selectable markereef1a
Selection (positive) procedurepyrimethamine
Selection (negative) procedureNo
Additional remarks genetic modificationGeneration of POFut2 KO: To replace POFut2, two fragments, F1 and F2, encompassing untranslated regions (UTRs) of the gene were amplified using primer pairs 1155/1156 (5′ UTR) and 1157/1158 (3′ UTR) and cloned at XhoI/SalI and NotI/AscI, respectively, in the pBC-GFP-hDHFR:yFCU vector. The vector was linearized using XhoI/AscI, transfected into schizonts.
Additional remarks selection procedure
Primer information: Primers used for amplification of the target sequences  Click to view information
Primer information: Primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Sequence Primer 3
Additional information primer 3
Sequence Primer 4
Additional information primer 4
Sequence Primer 5
Additional information primer 5
Sequence Primer 6
Additional information primer 6

  Transgene: Mutant parasite expressing a transgene
Type and details of transgene
Is the transgene Plasmodium derived Transgene: not Plasmodium
Transgene nameGFP
Details of the genetic modification
Inducable system usedNo
Additional remarks inducable system
Type of plasmid/construct(Linear) plasmid double cross-over
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid
Selectable marker used to select the mutant parasitehdhfr/yfcu
Promoter of the selectable markereef1a
Selection (positive) procedurepyrimethamine
Selection (negative) procedureNo
Additional remarks genetic modificationGeneration of POFut2 KO: To replace POFut2, two fragments, F1 and F2, encompassing untranslated regions (UTRs) of the gene were amplified using primer pairs 1155/1156 (5′ UTR) and 1157/1158 (3′ UTR) and cloned at XhoI/SalI and NotI/AscI, respectively, in the pBC-GFP-hDHFR:yFCU vector. The vector was linearized using XhoI/AscI, transfected into schizonts.
Additional remarks selection procedure
Other details transgene
Promoter
Gene Model of Parasite Not available
Gene Model P. falciparum ortholog Not available
Gene productNot available
Gene product: Alternative name
Primer information details of the primers used for amplification of the promoter sequence  Click to view information
Primer information details of the primers used for amplification of the promoter sequence  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
3'-UTR
Gene Model of Parasite Not available
Gene productNot available
Gene product: Alternative name
Primer information details of the primers used for amplification the 3'-UTR sequences  Click to view information
Primer information details of the primers used for amplification the 3'-UTR sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Insertion/Replacement locus
Replacement / InsertionInsertion locus
Gene Model of Parasite PBANKA_1110700
Gene productStearoyl-CoA desaturase
Gene product: Alternative nameScd
Primer information details of the primers used for amplification of the target sequences  Click to view information
Primer information details of the primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Sequence Primer 3
Additional information primer 3
Sequence Primer 4
Additional information primer 4